Advanced Cancer Antibody Drug Modalities Core Facility
Return to Resource DirectoryHouston
Contact:
Zhiqiang An, PhD
Director, Texas Therapeutics Institute, University of Texas Health Science Center at Houston
Email: [email protected]
Phone: (713) 500-3011
Website: https://www.uth.edu/imm/labs/antibody-drug-discovery/
The Advanced Cancer Antibody Drug Modalities Core Facility (RP190561) has expertise in four areas: 1) Lead identification; 2) Lead optimization; 3) Lead construction; and 4 Antibody production.